Phase II Study to Topotecan and Cisplatin in Advanced Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma remains a highly chemoresistant neoplasm and is a common malignancy with poor prognosis in Korea. We performed a phase II study to evaluate the efficacy and toxicities of topotecan and cisplatin combination chemotherapy for advanced hepatocellular carcinoma. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ga Young, Kim, Bong-Seog, Seo, Yeoung Tae, Choi, Seong Ho, Kim, Hye Jin, Choi, Dong Seog, Ko, Ji Young, Yang, Soo Hyun, Byun, Jong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2003
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531618/
https://www.ncbi.nlm.nih.gov/pubmed/12872448
http://dx.doi.org/10.3904/kjim.2003.18.2.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531618/
https://www.ncbi.nlm.nih.gov/pubmed/12872448
http://dx.doi.org/10.3904/kjim.2003.18.2.104

Ejemplares similares